PMID: 9179630Jan 1, 1997Paper

Depression in the community: the first pan-European study DEPRES (Depression Research in European Society)

International Clinical Psychopharmacology
J P LépineA Tylee

Abstract

DEPRESS (Depression Research in European Society) is the first large pan-European survey of depression in the community. A total of 13359 of the 78463 adults who participated in screening interviews across six countries were identified as suffering from depression, a 6-month prevalence of 17%. Major depression accounted for 6.9% of the cases of depression and minor depression for 1.8%. Depressed subjects in both these categories perceived that their working or social lives were substantially impaired by depressive symptoms. The remaining 8.3% of depressed subjects considered that their functional impairment was not substantial. A significant proportion of sufferers from depression (43%) failed to seek treatment for their depressive symptoms. Of those who did seek help (57%), most consulted a primary care physician, the frequency of consultation increasing with the severity of depression. Sufferers from major depression imposed the greatest demand on healthcare resources, making almost three times as many visits to their GP or family doctor as non-sufferers (4.4 vs 1.5 visits over 6 months). More than two-thirds of depressed subjects (69%) were not prescribed any treatment and when drug therapy was prescribed (31%), only 25% of ...Continue Reading

Citations

Apr 23, 2002·The Journal of Mental Health Policy and Economics·Patrizia BertoFortunato Rizzo
Jul 9, 2010·Social Psychiatry and Psychiatric Epidemiology·Michael MadianosCostas Stefanis
Jun 20, 2006·European Archives of Psychiatry and Clinical Neuroscience·Hans-Jürgen Möller
Dec 18, 2007·European Archives of Psychiatry and Clinical Neuroscience·S KasperH J Möller
Feb 7, 2012·Community Mental Health Journal·Anne KleinbergVeiko Vasar
Jan 12, 2007·Pharmacy World & Science : PWS·Franciska A M DesplenterGert Laekeman
Sep 22, 2011·Irish Journal of Medical Science·W CullenD Meagher
Feb 6, 2004·General Hospital Psychiatry·George I PapakostasMaurizio Fava
Jan 30, 2002·General Hospital Psychiatry·Ellen FrankJohn Cornell
May 19, 2000·Social Science & Medicine·P Bracke
Sep 27, 2000·European Psychiatry : the Journal of the Association of European Psychiatrists·J J López-IborF J Otero
Sep 27, 2000·European Psychiatry : the Journal of the Association of European Psychiatrists·J Borghi, J F Guest
Dec 1, 2001·European Psychiatry : the Journal of the Association of European Psychiatrists·A P Boardman, D Healy
Nov 26, 1999·European Psychiatry : the Journal of the Association of European Psychiatrists·M C BrownJ F Guest
Aug 10, 2004·Epidemiologia e psichiatria sociale·Corrado BarbuiUNKNOWN Sudy Group Dysco
Jan 19, 2000·Epidemiologia e psichiatria sociale·J CascianoR Casciano
Jul 9, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·A GandjourUNKNOWN INTERCARE International Investigators
Jun 10, 2010·Family Practice·Judith E BosmansMaurits W van Tulder
Sep 25, 2010·Family Practice·Kadri SuijaHeidi-Ingrid Maaroos
Apr 27, 2004·International Clinical Psychopharmacology·Renee RomeoChristine Thomas
Apr 27, 2004·International Clinical Psychopharmacology·A BattagliaP Pancheri
Apr 19, 2005·Spine·Afschin GandjourUNKNOWN INTERCARE International Investigators
Mar 30, 2005·Clinical Neuropharmacology·Vladimir LernerChanoch Miodownik
Jun 18, 2004·International Clinical Psychopharmacology·Afschin GandjourUNKNOWN INTERCARE International Investigators
Aug 4, 2004·International Clinical Psychopharmacology·Thomas R Einarson
Jan 27, 2006·International Clinical Psychopharmacology·Stuart A Montgomery
Aug 11, 2007·International Clinical Psychopharmacology·Stuart A Montgomery, Siegfried Kasper
Feb 28, 2008·International Clinical Psychopharmacology·Stuart A Montgomery
Mar 18, 2005·Seminars in Dialysis·Eliana TossaniMaurizio Fava
Apr 9, 2005·BMJ : British Medical Journal·Andre Tylee, Roger Jones
Jan 1, 2011·Archives of public health = Archives belges de santé publique·Elise PattynPiet Bracke
Jun 17, 2008·BMC Family Practice·Ranja StrombergLars G Backlund
May 11, 2005·BMC Public Health·Christoph LauberWulf Rössler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.